2,4,6-TRICHLOROPYRIDO[3,2-D]PYRIMIDINE, 97.0%, 250mg

2-Chloro-1-[3,3a,4,5,6,7-hexahydro-3-phenyl-7-(phenylmethylene)-2H-indazol-2-yl]ethanone, 250mg

2,4,5-Trichloro-7H-pyrrolo[2,3-d]pyrimidine, 95.0%, 10g

(R)-4,4-difluoropyrrolidine-2-carboxamide hydrochloride, 98%, 500mg

3-(tert-Butoxy)benzoic acid, 95.0%, 10g

1-(4-(Aminomethyl)piperidin-1-yl)prop-2-en-1-one, 98%, 50mg

4-Bromoisoquinolin-3-amine, 95.0%, 250mg

Amsacrine hydrochloride, 98%, 250mg

Pentafluorobenzamide>99.0%(GC)25g

ARCA Cap Analog, ≥98%, 10 µl, emballage plastique.

10H,10'H-[9,9'-Bianthracenylidene]-10,10'-dione, 95.0%, 1g

Bifendatatum, 95.0%, 10g

1-Propyl-1H-pyrazole-4-carbaldehyde, 95.0%, 1g